Page last updated: 2024-09-04

moxifloxacin and sultamicillin

moxifloxacin has been researched along with sultamicillin in 6 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (sultamicillin)	Trials (sultamicillin)	Recent Studies (post-2010) (sultamicillin)
3,157	552	1,690	578	120	164

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (33.33)	29.6817
2010's	3 (50.00)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E	1
Allewelt, M; Lode, H; Lorenz, J; Ott, SR; Reimnitz, P	1
Al-Nawas, B; d'Hoedt, B; Karbach, J; Mouratidou, A	1
Chen, CW; Ma, CJ; Ming, CC; Shan, YS; Wang, JY; Yeh, YS	1
Akgul, O; Jean-Pierre, H; Justesen, US; Kulekci, G; Morris, T; Nagy, E; Soyletir, G; Ulger Toprak, N; Urban, E; Veloo, ACM; Wybo, I	1
Ikebuchi, K; Imai, K; Kawamura, T; Kodana, M; Maeda, T; Maesaki, S; Mitsutake, K; Murakami, T; Ogane, K; Onodera, A; Sakai, J; Takeuchi, S; Tarumoto, N	1

Trials

2 trial(s) available for moxifloxacin and sultamicillin

Article	Year
Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess. Infection, 2008, Volume: 36, Issue:1 Topics: Adult; Ampicillin; Anti-Bacterial Agents; Aza Compounds; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Negative Facultatively Anaerobic Rods; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Lung Abscess; Male; Moxifloxacin; Pneumonia, Aspiration; Quinolines; Radiography; Sulbactam	2008
Prospective, randomized, study of ampicillin-sulbactam versus moxifloxacin monotherapy for the treatment of community-acquired complicated intra-abdominal infections. Surgical infections, 2013, Volume: 14, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Aza Compounds; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Intraabdominal Infections; Logistic Models; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Risk Factors; Sulbactam; Taiwan; Treatment Outcome; Young Adult	2013

Article

Year

Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess.

Infection, 2008, Volume: 36, Issue:1

Topics: Adult; Ampicillin; Anti-Bacterial Agents; Aza Compounds; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Negative Facultatively Anaerobic Rods; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Lung Abscess; Male; Moxifloxacin; Pneumonia, Aspiration; Quinolines; Radiography; Sulbactam

2008

Prospective, randomized, study of ampicillin-sulbactam versus moxifloxacin monotherapy for the treatment of community-acquired complicated intra-abdominal infections.

Surgical infections, 2013, Volume: 14, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Aza Compounds; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Intraabdominal Infections; Logistic Models; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Risk Factors; Sulbactam; Taiwan; Treatment Outcome; Young Adult

2013

Other Studies

4 other study(ies) available for moxifloxacin and sultamicillin

Article	Year
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:4 Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins	2001
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model. Journal of periodontology, 2011, Volume: 82, Issue:9 Topics: Acetamides; Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Capnocytophaga; Coculture Techniques; Coinfection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Metronidazole; Microbial Interactions; Minocycline; Moxifloxacin; Oxazolidinones; Penicillin G; Peptostreptococcus; Peri-Implantitis; Periodontitis; Quinolines; Sulbactam	2011
A multicenter survey of antimicrobial susceptibility of Prevotella species as determined by Etest methodology. Anaerobe, 2018, Volume: 52 Topics: Ampicillin; Anti-Bacterial Agents; Bacteroidaceae Infections; Clindamycin; Disk Diffusion Antimicrobial Tests; Fluoroquinolones; Humans; Kuwait; Meropenem; Metronidazole; Moxifloxacin; Prevotella; Sulbactam; Thienamycins; Turkey	2018
Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan. Anaerobe, 2020, Volume: 64 Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Blood Culture; DNA Transposable Elements; Doripenem; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Imipenem; Japan; Meropenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin, Tazobactam Drug Combination; Prevalence; Sulbactam; Tertiary Care Centers	2020